← Back to Search

Urokinase-type Plasminogen Activator

LTI-01 for Pleural Effusion

Phase 2
Waitlist Available
Research Sponsored by Lung Therapeutics, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male or female ≥ 18 years of age who provide written informed consent
Clinical presentation compatible with complicated parapneumonic pleural effusion (CPE), empyema or other type of pleural infection
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post treatment (day 4 or at time of treatment failure)
Awards & highlights

Study Summary

This trial is testing a new drug to see if it can treat patients with an infection in their lungs.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post treatment (day 4 or at time of treatment failure)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post treatment (day 4 or at time of treatment failure) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of referral to surgery
Secondary outcome measures
Relative change in pleural opacity

Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: 800,000 U LTI-01Experimental Treatment1 Intervention
800,000 U LTI-01 qd x 3 days administered intrapleurally
Group II: 400,000 U LTI-01Experimental Treatment1 Intervention
400,000 U LTI-01 once a day (qd) x 3 days administered intrapleurally
Group III: 1,200,000 U LTI-01Experimental Treatment1 Intervention
1,200,000 U LTI-01 qd x 3 days administered intrapleurally
Group IV: PlaceboPlacebo Group1 Intervention
placebo (normal saline) 6ml qd x 3 days administered intrapleurally
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Saruplase
Not yet FDA approved

Find a Location

Who is running the clinical trial?

Lung Therapeutics, IncLead Sponsor
2 Previous Clinical Trials
95 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~10 spots leftby Mar 2025